| Patients without T2DM | Patients with T2DM without hypoglycemia | Patients with T2DM and hypoglycemia |
---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | |
3P-MACE | Â | Â | Â |
 No. of cases (%) | 57 (14.8) | 71 (22.3) | 31 (39.2) |
 Model 1a | 1 [Reference] | 1.39 (0.98–1.97) | 2.67 (1.72–4.15) |
 Model 2b | 1 [Reference] | 1.64 (1.06–2.55) | 3.53 (1.92–6.49) |
 Model 3c | 1 [Reference] | 1.42 (0.86–2.33) | 2.29 (1.04–5.06) |
Cardiovascular mortality | Â | Â | Â |
 No. of cases (%) | 37 (9.6) | 37 (11.6) | 22 (27.8) |
 Model 1a | 1 [Reference] | 1.14 (0.72–1.81) | 3.28 (1.93–5.56) |
 Model 2b | 1 [Reference] | 1.46 (0.83–2.56) | 4.95 (2.35–10.42) |
 Model 3c | 1 [Reference] | 1.12 (0.61–2.07) | 2.87 (1.17–7.05) |
All-cause mortality | Â | Â | Â |
 No. of cases (%) | 55 (14.2) | 69 (21.7) | 34 (43.0) |
 Model 1a | 1 [Reference] | 1.42 (1.00–2.02) | 3.37 (2.15–5.19) |
 Model 2b | 1 [Reference] | 1.74 (1.13–2.69) | 4.53 (2.52–8.16) |
 Model 3c | 1 [Reference] | 1.32 (0.81–2.16) | 2.58 (1.26–5.31) |